NES-ZIONA, Israel, May 15 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company applying its patented technology to develop longer-acting versions of already approved therapeutic proteins, today announced that President Shai Novik will present at the upcoming Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference at 3:40 AM EDT (9:40 AM Central European Summer Time) on May 20, 2008.
The presentation will be webcast live and an archived version of the webcast will be available for approximately 90 days. The live and archived webcast can be accessed at http://wsw.com/webcast/rrshq13/modg.ob.
Modigene Inc. is a biopharmaceutical company applying its patented CTP
technology to develop longer-acting, proprietary versions of already
approved therapeutic proteins that currently generate billions of dollars
in annual global sales. The CTP technology is applicable to virtually all
proteins, and Modigene is currently developing long-acting versions of
human growth hormone, interferon beta and erythropoietin, which are in late
preclinical development, as well as GLP-1. For more information on
Modigene, visit http://www.modigeneinc.com.
MODIGENE CONTACT: MEDIA CONTACT:
Shai Novik, President Barbara Lindheim
Modigene Inc. GendeLLindheim BioCom Partners
Tel: +1 866 644-7811 +1 212 918-4650
|SOURCE Modigene Inc.|
Copyright©2008 PR Newswire.
All rights reserved